Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
Volume: 376, Issue: 22, Pages: 2134 - 2146
Published: Jun 1, 2017
Abstract
Patients who are chronically infected with hepatitis C virus (HCV) and who do not have a sustained virologic response after treatment with regimens containing direct-acting antiviral agents (DAAs) have limited retreatment...
Paper Details
Title
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
Published Date
Jun 1, 2017
Volume
376
Issue
22
Pages
2134 - 2146
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History